V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10007761 | 10005615 | 1.67 | 63 | Palliative (P) | 2019-12-13 | 2019-12-13 | CISPLATIN + ETOPOSIDE | 2 | N | 10553930 | CAPECITABINE + CARBOPLATIN + RT |
| 10007762 | 10005616 | 1.75 | 82 | Palliative (P) | 2017-10-08 | 2017-10-11 | CABOZANTINIB | 02 | N | 10559726 | PAZOPANIB |
| 10007763 | 10005617 | 1.67 | 69 | Curative (C) | 2018-07-16 | 2018-07-16 | OSIMERTINIB | N | N | 10560627 | BORTEZOMIB + THALIDOMIDE |
| 10007764 | 10005617 | 1.7 | 63.1 | Adjuvant (A) | 2019-01-27 | 2019-01-31 | EOX | N | null | 10560627 | ENZALUTAMIDE |
| 10007765 | 10005618 | 1.68 | null | Palliative (P) | 2017-11-21 | 2017-12-26 | NIVOLUMAB | 02 | N | 10562316 | NAB-PACLITAXEL |
| 10007766 | 10005621 | 1.64 | 67.6 | Palliative (P) | 2018-08-15 | 2018-08-22 | DOCETAXEL + TRASTUZUMAB | N | N | 10205908 | CARBOPLATIN + PACLITAXEL + RT |
| 10007767 | 10005622 | null | null | Curative (C) | null | 2019-02-24 | Cyclophosphamide High Dose | 2 | null | 10233873 | NAB-PACLITAXEL |
| 10007768 | 10005626 | 1.68 | 96 | Palliative (P) | 2019-05-22 | 2019-05-23 | Sunitinib | N | N | 10283621 | RUXOLITINIB |
| 10007769 | 10005627 | 1.82 | 95.3 | Palliative (P) | 2019-12-30 | 2019-12-30 | Cisplatin + Pemetrexed | N | N | 10300441 | OXALIPLATIN + RALTITREXED |
| 10007770 | 10005628 | null | 69.5 | Palliative (P) | 2017-10-01 | 2017-10-02 | IMATINIB | N | Y | 10317444 | PERTUZUMAB + TRASTUZUMAB |
| 10007771 | 10005628 | 1.84 | 58.7 | Curative (C) | 2019-09-29 | 2019-10-27 | EOX | N | N | 10317444 | MELPHALAN |
| 10007772 | 10005629 | null | 91.7 | Not known (9) | 2018-06-22 | 2018-06-22 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | N | N | 10330739 | DOCETAXEL + NINTEDANIB |
| 10007773 | 10005632 | 1.52 | null | null | 2018-03-09 | 2018-05-21 | Chlorambucil | N | N | 10336508 | RUXOLITINIB |
| 10007774 | 10005633 | 1.67 | 92.2 | Disease modification (D) | 2019-04-21 | 2019-04-21 | AML18 PILOT TRIAL | N | N | 10349419 | MELPHALAN |
| 10007775 | 10005634 | 1.75 | 93 | Not known (9) | 2017-09-28 | 2017-09-28 | PIN TRIAL | 2 | null | 10350333 | PAZOPANIB |
| 10007776 | 10005638 | null | 95.5 | Curative (C) | 2017-10-05 | 2017-10-05 | BOSUTINIB | N | N | 10350333 | CETUXIMAB + RT |
| 10007777 | 10005639 | 1.75 | 94.1 | Not known (9) | 2018-07-27 | 2018-07-27 | Sunitinib | N | N | 10397847 | BORTEZOMIB |
| 10007778 | 10007787 | 1.5 | 76.9 | Curative (C) | 2019-03-08 | 2019-03-08 | MELPHALAN | N | null | 10400059 | MELPHALAN |
| 10007779 | 10005640 | 2 | 76.8 | null | 2016-09-25 | 2016-09-26 | Capecitabine + Cisplatin | N | N | 10407160 | SUNITINIB |
| 10007780 | 10005641 | 1.73 | 65.2 | null | 2019-04-16 | 2019-04-19 | Cape+Cisplatin+Trastuzumab Main | N | N | 10407956 | ENZALUTAMIDE |
| 10007781 | 10007788 | 1.71 | 93.7 | Palliative (P) | 2018-03-14 | 2018-06-12 | CARFILZOMIB | N | null | 10412890 | EOX |
| 10007782 | 10005642 | 1.64 | 60.4 | Palliative (P) | 2019-12-23 | 2019-12-23 | Docetaxel + Nintedanib | N | null | 10457248 | CISPLATIN + GEMCITABINE |
| 10007783 | 10005643 | null | 83.1 | Disease modification (D) | null | 2019-05-14 | R Chlorambucil | 02 | N | 10461654 | LEGEND TRIAL |
| 10007784 | 10005644 | 1.7 | 72.6 | Palliative (P) | 2018-01-03 | 2018-01-18 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 1 | Y | 10519374 | FEC |
| 10007785 | 10005645 | 1.73 | 78.6 | Palliative (P) | 2016-03-13 | 2016-06-06 | Ipilimumab | N | N | 10530156 | FLUOROURACIL + MITOMYCIN + RT |
| 10007786 | 10005648 | 1.67 | 0 | Palliative (P) | 2017-01-24 | 2017-01-24 | CODOX M | 1 | N | 10535413 | NIVOLUMAB |
| 10007787 | 10005649 | 1.62 | null | Neo-adjuvant (N) | 2017-01-04 | 2017-01-04 | AML18 PILOT TRIAL | null | N | 10539005 | BORTEZOMIB + THALIDOMIDE |
| 10007788 | 10005650 | 1.71 | 92.4 | Palliative (P) | 2018-02-06 | 2018-02-17 | Cisplatin + Pemetrexed | N | N | 10545759 | BORTEZOMIB |
| 10007789 | 10003529 | null | 73.4 | Adjuvant (A) | 2017-07-17 | 2017-07-26 | PEMBROLIZUMAB | 02 | N | 10100460 | PEMBROLIZUMAB |
| 10007790 | 10003530 | 1.75 | null | Palliative (P) | 2015-03-26 | 2015-04-06 | TRASTUZUMAB | 2 | N | 10126144 | TRASTUZUMAB |
| 10007791 | 10003532 | null | 83.75 | Adjuvant (A) | 2014-09-24 | 2014-09-24 | Rituximab | 02 | N | 10127587 | RITUXIMAB |
| 10007792 | 10003536 | null | 58 | Curative (C) | null | 2014-01-22 | PEMBROLIZUMAB | N | N | 10254921 | PEMBROLIZUMAB |
| 10007793 | 10003542 | 1.83 | 101.6 | Palliative (P) | null | 2018-03-25 | PACLITAXEL | 2 | N | 10406386 | PACLITAXEL |
| 10007794 | 10003542 | 1.7 | null | Adjuvant (A) | 2015-09-04 | 2015-11-10 | Capecitabine + Oxaliplatin 21day | 02 | null | 10406386 | CAPECITABINE + OXALIPLATIN |
| 10007795 | 10003544 | 1.67 | 66 | Curative (C) | 2015-04-17 | 2015-08-07 | Docetaxel | N | N | 10483135 | DOCETAXEL |
| 10007796 | 10003548 | 1.71 | null | Palliative (P) | 2019-07-27 | 2019-10-29 | Oxaliplatin + Modified de Gramont | 02 | N | 10064622 | OXALIPLATIN + MDG |
| 10007797 | 10003550 | 1.7 | 82.4 | Palliative (P) | 2016-09-28 | 2016-10-18 | Capecitabine + Oxaliplatin 21day | N | N | 10065955 | CAPECITABINE + OXALIPLATIN |
| 10007798 | 10003553 | 1.78 | 94.25 | Palliative (P) | 2015-07-27 | 2015-08-16 | Trastuzumab Subcutaneous | Y | N | 10127559 | TRASTUZUMAB |
| 10007799 | 10003554 | 1.72 | null | Palliative (P) | 2016-06-01 | 2016-06-02 | Docetaxel | N | N | 10162550 | DOCETAXEL |
| 10007800 | 10006930 | 1.72 | 70.8 | Disease modification (D) | 2017-02-12 | 2017-02-12 | PEMBROLIZUMAB | 02 | null | 10229380 | PEMBROLIZUMAB |
| 10007801 | 10006931 | 1.64 | 72 | Disease modification (D) | 2015-12-04 | 2015-12-06 | Trastuzumab 21 day maintenance | N | N | 10230548 | TRASTUZUMAB |
| 10007802 | 10003565 | 1.65 | 68.4 | Curative (C) | 2007-03-01 | 2017-11-13 | Irinotecan + Modified De Gramont | 2 | N | 10234123 | IRINOTECAN + MDG |
| 10007803 | 10008317 | 1.65 | 78.3 | Palliative (P) | 2018-10-15 | 2018-10-19 | Docetaxel | N | N | 10234178 | DOCETAXEL |
| 10007804 | 10003567 | 1.53 | 59 | Palliative (P) | 2015-02-17 | 2015-02-17 | Trastuzumab 21 day maintenance | N | N | 10235097 | TRASTUZUMAB |
| 10007805 | 10003571 | 1.7 | 94 | Palliative (P) | 2015-09-18 | 2015-09-18 | Capecitabine + Oxaliplatin 21day | 02 | N | 10236572 | CAPECITABINE + OXALIPLATIN |
| 10007806 | 10008319 | 1.61 | 68 | Disease modification (D) | null | 2017-03-11 | Trastuzumab Subcutaneous | 02 | N | 10241016 | TRASTUZUMAB |
| 10007807 | 10003578 | 1.64 | 80 | Unknown (U) | 2019-05-08 | 2019-06-04 | Rituximab | N | N | 10242036 | RITUXIMAB |
| 10007808 | 10003584 | 1.59 | 68 | Curative (C) | 2018-06-11 | 2018-07-02 | CHOP R | 02 | N | 10244758 | CHOP R |
| 10007809 | 10003587 | 1.72 | 64.2 | Palliative (P) | 2018-11-13 | 2018-11-13 | PEMBROLIZUMAB | 2 | N | 10245567 | PEMBROLIZUMAB |
| 10007810 | 10003590 | null | 74.2 | Palliative (P) | 2016-04-17 | 2016-04-17 | Docetaxel 75mg/m2 (21 day) | 02 | null | 10245829 | DOCETAXEL |